Bio Solutions Corp. (OTCBB: BISU), Markets Very Effective Products to Counter Malaria

Over 300 million people are infected, more than one million children (under the age of five years) die by cause of Malaria each year. Bio-Solutions Corp. will market new and very effective organic products to counter Malaria and other High priority illnesses. Malaria is the forefront of priorities for the World Health Organization. The GREENEX product, is an organic insecticide available in solid or liquid form that attack Malaria at its core!

Free Hot Penny Stocks, an online financial publication, provides investors timely stock market alerts. Free hot penny stocks profiles stock picks that could generate higher returns than average. These penny stocks include stocks with news, chart breakouts or increased volume.

Sign Up Today for our Penny Stock Newsletter

"This organic product can be as useful in both veterinary care and human care. GREENEX formulations are produced in the USA to Strict manufacturer specifications. GREENEX, is produced from a strain of Bacillus thuringiensis subspecies israelensis (Bti). A naturally occurring bacterium that produces a crystalline protein toxin (crystal) and a spore. Bti formulations are FDA approved. Bio-Solutions Corp. will advocate a specialized market strategy for GREENEX. We will offer this product as a viable alternative to the countries dissatisfied with the service offered by the multinationals. In certain cases, the demands in services and products are too small to interest these large corporations, which is not, in our case" indicated Dr. Gilles Chaumillon PhD/MBA, CEO of Bio-Solutions Corp.GREENEX neutralizes and eradicates up to 98% of the larvae, within only 24 hours. Malaria is the most dangerous disease transmissible by mosquitoes that we know of.

“We would like to significantly increase the resources needed to address malaria through World Bank Roll Back malaria financing. We estimate that we now have re-allocated somewhere between US$ 100-150 million of RBM activities in our Africa region health portfolio, a healthy amount already available for malaria at the country level. However, we can do much more. We estimate that we can finance an additional US$ 300-500 million for RBM action across Africa and we hope that the RBM partnership and the African leadership will be instrumental in specifically creating a demand for the World Bank operations in this direction. The resources can be deployed to increase the fight against malaria, but there has to be an explicit country-driven, country-owned and country-prioritisation in order to win that fight," stated Mr. Eduardo Doryan, Vice-President for Human Development, The World Bank

Sign Up for Free Hot Penny Stocks’ FREE Penny Stock Newsletter.

About Us

Free Hot Penny Stocks is a financial website and independent electronic publication that provides information and free penny stock alerts on selected publicly traded companies. We also track small cap companies and other stocks that may be positioned to break out. These penny stocks might have news, increased volume or chart breakouts. These penny stocks that are alerted could generate greater than average returns. Feel free to visit our penny stock forum to discuss other penny stock picks or penny stocks that you might own.

Free Hot Penny Stocks is not a registered investment advisor or broker-dealer. Please do your own Due Diligence before investing in any of the stocks mentioned above. To feature a company on our web site please contact us at the email listed below.

Please click here to read the full disclaimer